Listen to part 2 of the three-part series "Keeping up with the Chemos" focusing on prevention and monitoring of Interstitial Lung Disease (ILD). Moderator: Jennifer MacDonald, PharmD, BCOP Speakers: Charles Powell, MD, MBA Paolo Tarantino, MD, PhD Ira Winer MD, PhD, FACOG Find the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract).

Listen to part 1 of the three-part series "Keeping up with the Chemos" on the therapies associated with Interstitial Lung Disease (ILD). Moderator: Jennifer MacDonald, PharmD, BCOP Speakers: Charles Powell, MD, MBA Paolo Tarantino, MD, PhD Ira Winer MD, PhD, FACOG Find the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract).

Listen to part 3 of the three-part series "Keeping up with the Chemos" focusing on the treatment of Interstitial Lung Disease (ILD). Moderator: Jennifer MacDonald, PharmD, BCOP Speakers: Charles Powell, MD, MBA Paolo Tarantino, MD, PhD Ira Winer MD, PhD, FACOG Find the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract).

Kaitlin Nicholson, MD and Katherine Tucker, MD, from the SGO Coding and Reimbursement Committee share their expertise in time-based coding to support your billing of inpatient and outpatient visits. One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Committee.

Carolyn Haunschild , MD and Sameer Sharma, MD, from the SGO Coding and Reimbursement Subcommittee share their expertise in E/M coding and discuss how risk of complications, morbidity and mortality of patient management factor into billing of inpatient and outpatient visits. One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Subcommittee.

Kimberly Levinson, MD, MPH, and Kaitlin Nicholson, MD, from the SGO Coding and Reimbursement Committee share their expertise in E/M coding to demystify the use of medical complexity data to support your billing of inpatient and outpatient visits. One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Committee.

As we all know, cancer care can feel incredibly complicated and overwhelming to patients – many of whom may face logistical, financial, and social barriers. Tune in to part two, as the discussion continues between Dr. Emily Wu and the panel of nurse navigators on the multi-faceted function of navigators and how to incorporate nurse navigation into a clinical practice. Moderator: Emily Wu, MD Overlake Medical Center Speakers: Julie Rodriguez, BSN, RN, OCN University of ...

As we all know, cancer care can feel incredibly complicated and overwhelming to patients – many of whom may face logistical, financial, and social barriers. Given the complexities of our healthcare systems, this episode provides insight on ways a clinical practice can better support their patients. Tune in to this two-part episode as the Dr. Emily Wu interviews a panel of nurse navigators on their unique experiences within the role, the multi-faceted function of navigators, and how to incorp...

Allison Barrie, MD, and Stephen Bush, MD, from the SGO Coding and Reimbursement Subcommittee share their expertise in E/M coding to unlock the secrets of using the number and complexity of diagnoses to support your billing of inpatient and outpatient visits. One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Chair of the SGO Coding and Reimbursement Subcommittee.

During the SGO 2024 Winter Meeting, Wellness Committee volunteers asked SGO members what advice they would give to their younger selves. Members at various stages of their medical career offered words of wisdom for trainees and new attendings in gynecologic oncology. Tune in to hear about challenges that members experienced, their journey to growth and self-care, and how they learned to find support through community and mentorship. Moderator: Hui (Amy) Chen, MD Speakers: Katherine Fuh,...

Listen to Dr. Jennifer MacDonald interview Drs. Scott Richard and Rachel Danis, discussing the importance of fertility preservation for cancer patients, partnering with a reproductive endocrinology and infertility clinic (REI) to expand fertility options for future family building, and patients utilizing grant/nonprofit funding resources to financially assist with fertility treatment options. 2024-2025 SGO Chemotherapy Immunotherapy Subcommittee Lead and Moderator: Jennifer MacDonald, PharmD...

Maximizing reproductive fertility options is just as important as beating cancer, primarily bridging the gap for patient education and fertility resources. Join Dr. Jennifer MacDonald as she interviews Drs. Scott Richard and Rachel Danis, addressing premature ovarian failure, ovarian preservation, and how chemo agents, radiation, and surgery can affect the patient’s natural fertility options. 2024-2025 SGO Chemotherapy and Immunotherapy Subcommittee Lead and Moderator: Jennifer MacDona...

This is the first of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. After going over some general information on CDK 4/6 inhibitors including when to use the drug, toxicity, response rates, repeat biopsy, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving CDK 4/6 inhibitors. The session wraps up with some key take home points on CDK 4/6 inhibitors. 2024-2025 SGO Chemotherapy and Immunolo...

This is the second of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of CDK 4/6 inhibitors. Focusing on dosing, supportive care, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 2024-2025 SGO Chemotherapy and Immunology Subcommittee Lead and Moderator: Jennifer Mac...

This is the last of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. Our multidisciplinary panel will discuss the challenges with patient monitoring while on CDK 4/6 inhibitors. When to dose adjust and hold or even discontinue CDK 4/6 inhibitors. Once again, the podcast ends with take home points for patient monitoring, medication management, and side effects while on CDK 4/6 inhibitors. 2024-2025 SGO Chemotherapy and Immunology Subcommittee Lead and Mod...

Let’s do this -- This podcast features patient advocates who share their experiences and offer valuable insights from their journeys as cervical cancer patients and survivors. It is hosted by the Health Equity Subcommittee, a division of the SGO Diversity, Inclusion, and Health Equity (DIHE) Committee. Moderators: Lindsay Kuroki, MD, MSCI, Washington University Physicians, DIHE Health Equity subcommittee ChairNancy Zhou, MD, Rutgers Health - NJMS, DIHE Health Equity subcommittee Member ...

This is the second of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trastuzumab Deruxtecan ENHERTU®. Focusing on dosing, breast scoring, HER2, infusion reactions, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 2023-2024 SGO...

This is the last of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trastuzumab Deruxtecan ENHERTU®. When to dose adjust and hold or even discontinue Trastuzumab Deruxtecan ENHERTU®. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trastuzumab Deruxtecan ENHERTU®. 2023-2024 SGO Chemotherapy and Targeted...

This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. After going over some general information on Trastuzumab Deruxtecan ENHERTU® including when to use the drug, checking patient performance status, toxicity, response rates in breast, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving Trastuzumab Deruxtecan ENHERTU®. The session wraps up with some key take home ...

In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS). Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity. Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and m...